Cargando…

Neurodegeneration and its potential markers in the diagnosing of secondary progressive multiple sclerosis. A review

Approximately 70% of relapsing-remitting multiple sclerosis (RRMS) patients will develop secondary progressive multiple sclerosis (SPMS) within 10–15 years. This progression is characterized by a gradual decline in neurological functionality and increasing limitations of daily activities. Growing ev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pogoda-Wesołowska, Aleksandra, Dziedzic, Angela, Maciak, Karina, Stȩpień, Adam, Dziaduch, Marta, Saluk, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535108/ https://www.ncbi.nlm.nih.gov/pubmed/37781097 http://dx.doi.org/10.3389/fnmol.2023.1210091

Ejemplares similares

Remyelination in multiple sclerosis from the miRNA perspective
por: Maciak, Karina, et al.
Publicado: (2023)

miR-155 as an Important Regulator of Multiple Sclerosis Pathogenesis. A Review
por: Maciak, Karina, et al.
Publicado: (2021)

Th17-Related Cytokines as Potential Discriminatory Markers between Neuromyelitis Optica (Devic’s Disease) and Multiple Sclerosis—A Review
por: Maciak, Karina, et al.
Publicado: (2021)

The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2021)

Circulating miRNAs as Potential Biomarkers Distinguishing Relapsing–Remitting from Secondary Progressive Multiple Sclerosis. A Review
por: Pietrasik, Sylwia, et al.
Publicado: (2021)

Increased level of fibrinogen chains in the proteome of blood platelets in secondary progressive multiple sclerosis patients
por: Bijak, Michal, et al.
Publicado: (2019)

Increased Pro-Thrombotic Platelet Activity Associated with Thrombin/PAR1-Dependent Pathway Disorder in Patients with Secondary Progressive Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2020)

Mean Platelet Volume as a Potential Marker of Large Vessel Occlusion and Predictor of Outcome in Acute Ischemic Stroke Patients Treated with Reperfusion Therapy
por: Dębiec, Aleksander, et al.
Publicado: (2021)

Oxidative Damage of Blood Platelets Correlates with the Degree of Psychophysical Disability in Secondary Progressive Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2020)

The Level of Isoprostanes as a Non-invasive Marker for in vivo Lipid Peroxidation in Secondary Progressive Multiple Sclerosis
por: Miller, Elżbieta, et al.
Publicado: (2011)

Probiotics and Commensal Gut Microbiota as the Effective Alternative Therapy for Multiple Sclerosis Patients Treatment
por: Dziedzic, Angela, et al.
Publicado: (2022)

The GPR17 Receptor—A Promising Goal for Therapy and a Potential Marker of the Neurodegenerative Process in Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2020)

Pro-Thrombotic Activity of Blood Platelets in Multiple Sclerosis
por: Saluk-Bijak, Joanna, et al.
Publicado: (2019)

Metformin as a Potential Agent in the Treatment of Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2020)

The Molecular Aspects of Disturbed Platelet Activation through ADP/P2Y(12) Pathway in Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2021)

A Review of Various Antioxidant Compounds and their Potential Utility as Complementary Therapy in Multiple Sclerosis
por: Miller, Elzbieta Dorota, et al.
Publicado: (2019)

The increased level of COX-dependent arachidonic acid metabolism in blood platelets from secondary progressive multiple sclerosis patients
por: Morel, Agnieszka, et al.
Publicado: (2016)

Relationship between the Increased Haemostatic Properties of Blood Platelets and Oxidative Stress Level in Multiple Sclerosis Patients with the Secondary Progressive Stage
por: Morel, Agnieszka, et al.
Publicado: (2015)

Association of a Marker of N-Acetylglucosamine With Progressive Multiple Sclerosis and Neurodegeneration
por: Brandt, Alexander U., et al.
Publicado: (2021)

Variation of genes encoding nitric oxide synthases and antioxidant enzymes as potential risks of multiple sclerosis development: a preliminary study
por: Wigner, Paulina, et al.
Publicado: (2022)

Heart rate variability as a predictor of stroke course, functional outcome, and medical complications: A systematic review
por: Aftyka, Joanna, et al.
Publicado: (2023)

Can HRV Predict Prolonged Hospitalization and Favorable or Unfavorable Short-Term Outcome in Patients with Acute Ischemic Stroke?
por: Aftyka, Joanna, et al.
Publicado: (2023)

Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis
por: Correale, Jorge, et al.
Publicado: (2019)

Screening Analysis of Platelet miRNA Profile Revealed miR-142-3p as a Potential Biomarker in Modeling the Risk of Acute Coronary Syndrome
por: Szelenberger, Rafał, et al.
Publicado: (2021)

Inhibitory Effect of Flavonolignans on the P2Y12 Pathway in Blood Platelets
por: Bijak, Michal, et al.
Publicado: (2018)

Chronic Progressive Multiple Sclerosis – Pathogenesis of Neurodegeneration and Therapeutic Strategies
por: Fitzner, Dirk, et al.
Publicado: (2010)

Gender effect on neurodegeneration and myelin markers in an animal model for multiple sclerosis
por: Massella, Alessandro, et al.
Publicado: (2012)

Neurodegeneration in multiple sclerosis
por: Mey, Gabrielle M., et al.
Publicado: (2022)

The Hemisphere of the Brain in Which a Stroke Has Occurred Visible in the Heart Rate Variability
por: Aftyka, Joanna, et al.
Publicado: (2022)

Flavonolignans Inhibit IL1-β-Induced Cross-Talk between Blood Platelets and Leukocytes
por: Bijak, Michal, et al.
Publicado: (2017)

Flow cytometric analysis reveals the high levels of platelet activation parameters in circulation of multiple sclerosis patients
por: Morel, Agnieszka, et al.
Publicado: (2017)

Secondary Progressive Multiple Sclerosis: New Insights
por: Cree, Bruce A.C., et al.
Publicado: (2021)

Iron and Neurodegeneration in Multiple Sclerosis
por: Khalil, Michael, et al.
Publicado: (2011)

Effects of different models of sucrose intake on the oxidative status of the uterus and ovary of rats
por: Sadowska, Joanna, et al.
Publicado: (2021)

The Effect of Alternating High-Sucrose and Sucrose Free-Diets, and Intermittent One-Day Fasting on the Estrous Cycle and Sex Hormones in Female Rats
por: Sadowska, Joanna, et al.
Publicado: (2022)

Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics
por: Kamma, Emily, et al.
Publicado: (2022)

N-acetylglucosamine inhibits inflammation and neurodegeneration markers in multiple sclerosis: a mechanistic trial
por: Sy, Michael, et al.
Publicado: (2023)

Association of CSF and PET markers of neurodegeneration with electroclinical progression in Lafora disease
por: d'Orsi, Giuseppe, et al.
Publicado: (2023)

Pharmacological and Non-pharmacological Therapies of Cognitive Impairment in Multiple Sclerosis
por: Miller, Elżbieta, et al.
Publicado: (2018)

Mitochondrial dysfunction and neurodegeneration in multiple sclerosis
por: Su, Kimmy, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1us4ovg2ik157ttv99un9dpahg